These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 26525951)

  • 1. Development and Characterization of the Recombinant Human VEGF-EGF Dual-Targeting Fusion Protein as a Drug Delivery System.
    Li JJ; Lan KL; Chang SF; Chen YF; Tsai WC; Chiang PH; Lin MH; Fischer WB; Shih YS; Yen SH; Liu RS; Tsay YG; Wang HE; Chang CA
    Bioconjug Chem; 2015 Dec; 26(12):2481-96. PubMed ID: 26525951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
    Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
    J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy.
    Cornelissen B; Darbar S; Hernandez R; Kersemans V; Tullis I; Barber PR; Smart S; Vojnovic B; Reilly R; Vallis KA
    J Nucl Med; 2011 May; 52(5):776-83. PubMed ID: 21498540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [177Lu]Bz-DTPA-EGF: Preclinical characterization of a potential radionuclide targeting agent against glioma.
    Sundberg AL; Gedda L; Orlova A; Bruskin A; Blomquist E; Carlsson J; Tolmachev V
    Cancer Biother Radiopharm; 2004 Apr; 19(2):195-204. PubMed ID: 15186600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of non-biologically active truncated EGF (EGFt) and full-length hEGF for delivery of Auger electron-emitting 111In to EGFR-positive breast cancer cells and tumor xenografts in athymic mice.
    Panosa C; Fonge H; Ferrer-Batallé M; Menéndez JA; Massaguer A; De Llorens R; Reilly RM
    Nucl Med Biol; 2015 Dec; 42(12):931-8. PubMed ID: 26385534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor inhibition modulates the nuclear localization and cytotoxicity of the Auger electron emitting radiopharmaceutical 111In-DTPA human epidermal growth factor.
    Bailey KE; Costantini DL; Cai Z; Scollard DA; Chen Z; Reilly RM; Vallis KA
    J Nucl Med; 2007 Sep; 48(9):1562-70. PubMed ID: 17704253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor-conjugated poly(ethylene glycol)-block- poly(delta-valerolactone) copolymer micelles for targeted delivery of chemotherapeutics.
    Zeng F; Lee H; Allen C
    Bioconjug Chem; 2006; 17(2):399-409. PubMed ID: 16536472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [(111)In]Bz-DTPA-hEGF: Preparation and in vitro characterization of a potential anti-glioblastoma targeting agent.
    Sundberg AL; Orlova A; Bruskin A; Gedda L; Carlsson J; Blomquist E; Lundqvist H; Tolmachev V
    Cancer Biother Radiopharm; 2003 Aug; 18(4):643-54. PubMed ID: 14503960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer.
    Reilly RM; Kiarash R; Sandhu J; Lee YW; Cameron RG; Hendler A; Vallis K; Gariépy J
    J Nucl Med; 2000 May; 41(5):903-11. PubMed ID: 10809207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-Receptor-Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using 177Lu- or 111In-Labeled Bispecific Radioimmunoconjugates.
    Razumienko EJ; Chen JC; Cai Z; Chan C; Reilly RM
    J Nucl Med; 2016 Mar; 57(3):444-52. PubMed ID: 26429962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
    Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A human transferrin-vascular endothelial growth factor (hnTf-VEGF) fusion protein containing an integrated binding site for (111)In for imaging tumor angiogenesis.
    Chan C; Sandhu J; Guha A; Scollard DA; Wang J; Chen P; Bai K; Lee L; Reilly RM
    J Nucl Med; 2005 Oct; 46(10):1745-52. PubMed ID: 16204726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjugation with (111)In-DTPA-poly(ethylene glycol) improves imaging of anti-EGF receptor antibody C225.
    Wen X; Wu QP; Ke S; Ellis L; Charnsangavej C; Delpassand AS; Wallace S; Li C
    J Nucl Med; 2001 Oct; 42(10):1530-7. PubMed ID: 11585869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of formulation variables on the biodistribution of multifunctional block copolymer micelles.
    Fonge H; Huang H; Scollard D; Reilly RM; Allen C
    J Control Release; 2012 Feb; 157(3):366-74. PubMed ID: 21982897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor-ferritin H-chain protein nanoparticles for tumor active targeting.
    Li X; Qiu L; Zhu P; Tao X; Imanaka T; Zhao J; Huang Y; Tu Y; Cao X
    Small; 2012 Aug; 8(16):2505-14. PubMed ID: 22619186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR.
    Reilly RM; Kiarash R; Cameron RG; Porlier N; Sandhu J; Hill RP; Vallis K; Hendler A; Gariépy J
    J Nucl Med; 2000 Mar; 41(3):429-38. PubMed ID: 10716315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a human epidermal growth factor derivative with EGFR-blocking and depleted biological activities: A comparative in vitro study using EGFR-positive breast cancer cells.
    Mehrabi M; Mansouri K; Soleymani B; Hoseinkhani Z; Shahlaie M; Khodarahmi R
    Int J Biol Macromol; 2017 Oct; 103():275-285. PubMed ID: 28501600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.
    Ke S; Wen X; Gurfinkel M; Charnsangavej C; Wallace S; Sevick-Muraca EM; Li C
    Cancer Res; 2003 Nov; 63(22):7870-5. PubMed ID: 14633715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the EGFR density of breast cancer cells on nuclear importation, in vitro cytotoxicity, and tumor and normal-tissue uptake of [111In]DTPA-hEGF.
    Hu M; Scollard D; Chan C; Chen P; Vallis K; Reilly RM
    Nucl Med Biol; 2007 Nov; 34(8):887-96. PubMed ID: 17998090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative biodistribution of potential anti-glioblastoma conjugates [111In]DTPA-hEGF and [111In]Bz-DTPA-hEGF in normal mice.
    Tolmachev V; Orlova A; Wei Q; Bruskin A; Carlsson J; Gedda L
    Cancer Biother Radiopharm; 2004 Aug; 19(4):491-501. PubMed ID: 15453964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.